Relapsed or Refractory Lymphoma or Advanced Cancer
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Lymphoma or Advanced Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of TQ-B3525 on Tolerance and Pharmacokinetics (NCT03510767) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2018-06-20 |
Track Relapsed or Refractory Lymphoma or Advanced Cancer automatically
Every clearance here is in the API, with alerts when new ones post.